Astex Pharmaceuticals, Inc.
Records under this name other than patents Astex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Astex Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,710,057 | Imidazo[1,2-b]pyridazine and Pyrazolo[1,5-a]pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors now held by Sumitomo Pharma America, Inc. In force · High confidence | In force | High confidence | |
| US 7,750,007 | Imidazo[1,2-beta]pyridazine and PYRAZOLO[1,5-Alpha]PYRIMIDINE Derivatives and Their Use as Protein Kinase Inhibitors now held by Sumitomo Pharma America, Inc. In force · High confidence | In force | High confidence | |
| US 12,239,653 | Combination Decitabine and Cedazuridine Solid Oral Dosage Forms conveyed to Otsuka Pharmaceutical Co. Ltd. - now held by Taiho Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 12,187,757 | 2'-Deoxy-2',2'-Difluorotetrahydrouridines with High Purity and Methods of Making the Same conveyed to Otsuka Pharmaceutical Co. Ltd. - now held by Taiho Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 12,697,347 | Pharmaceutical Compositions and Methods of Using the Same for Treating Cancer conveyed to Otsuka Pharmaceutical Co. Ltd. - now held by Taiho Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 9,913,856 | Drug formulations Lapsed on the fee record Ended Mar 13, 2026 · High confidence | Lapsed on the fee record | Ended Mar 13, 2026 | High confidence |
| US 7,700,567 | Oligonucleotide Analogues Incorporating 5-AZA-CYTOSINE Therein Term ended Term ended Sep 29, 2025 · High confidence | Term ended | Term ended Sep 29, 2025 | High confidence |
| US 11,058,705 | Drug Formulations Lapsed on the fee record Ended Jul 13, 2025 · High confidence | Lapsed on the fee record | Ended Jul 13, 2025 | High confidence |
| US 8,461,123 | Oligonucleotide Analogues Incorporating 5-AZA-CYTOSINE Therein Lapsed on the fee record Ended Jun 11, 2025 · High confidence | Lapsed on the fee record | Ended Jun 11, 2025 | High confidence |
| US 7,250,416 | Azacytosine Analogs and Derivatives Term ended Term ended Mar 11, 2025 · High confidence | Term ended | Term ended Mar 11, 2025 | High confidence |